Most sources consider breastfeeding to be contraindicated during maternal antineoplastic drug therapy, although the evidence for this recommendation for hydroxyurea is very weak.[1,2] Chemotherapy may adversely affect the normal microbiome and chemical makeup of breastmilk.[3]